NCT00053339 Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer Status WITHDRAWN Phase PHASE3
NCT00047255 Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT00042809 Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00041067 S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00039455 Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer Status TERMINATED Phase PHASE1
NCT00036868 Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00033514 Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression Status COMPLETED Phase PHASE1/PHASE2
NCT00028535 Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00024154 Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00023998 Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma Status COMPLETED Phase PHASE2
NCT00022529 BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00019812 Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 Status COMPLETED Phase PHASE2
NCT00016367 Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Status TERMINATED Phase PHASE3
NCT00014430 Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer Status COMPLETED Phase PHASE1
NCT00009997 Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00006825 Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00006381 Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00006228 Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00006123 Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer Status WITHDRAWN Phase PHASE1/PHASE2